Evtol Market Is Forecasted To Reach US$ 3.2 Billion In 2040, Says Stratview Research
Stratview Research, a global market research firm, has launched a report on the global eVTOL market, which provides a comprehensive outlook of the global and regional industry forecast, current & ...
Preclinical Intranasal COVID-19 Vaccine Candidate Data Demonstrate Durable Immune Response and Broad Protection
Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...
Frontiers27d
Commentary: Inactivated rabies virus vectored MERS-Coronavirus vaccine induces protective immunity in mice, camels, and alpacas
In the field of virus-vectored vaccines, Chi et al. carried out their study that was valuable for guiding the development of IRVV. In conclusion, the inactivated rSRV9-MERS S1 was safe for the vaccine ...